This post is from a low-reputation account and contains an unverified outbound link. Be cautious before clicking external links.
How Aromatase Inhibitors Are Revolutionizing Hormone-Responsive Breast Cancer Therapy
Words
44
Reading
1 min
Listen
Play
2y
Breast cancer, a life-altering diagnosis for millions of women globally, remains one of the most researched areas in oncology. Among the various treatment modalities, hormone-responsive breast cancer therapies have seen significant breakthroughs. Aromatase inhibitors (AIs) have revolutionised the management of hormone receptor-positive breast cancers.